āļŠāļāļļāļĨāđ€āļ‡āļīāļ™āļ„āļĢāļīāļ›āđ‚āļ•
āļ•āļĨāļēāļ”āļāļēāļĢāļ„āļēāļ”āļāļēāļĢāļ“āđŒ
āļ•āļąāļ§āļāļĨāļēāļ‡āļāļēāļĢāđāļĨāļāđ€āļ›āļĨāļĩāđˆāļĒāļ™
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ”āļīāļˆāļīāļ—āļąāļĨāđ‚āļ”āļĒāļœāđˆāļēāļ™āļ„āļ™āļāļĨāļēāļ‡:
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ”āļīāļˆāļīāļ—āļąāļĨāđ‚āļ”āļĒāđ„āļĄāđˆāļĄāļĩāļ„āļ™āļāļĨāļēāļ‡:

Merck & Co Inc stock price
MRK
#45

āļŋ3,917.39
  

1.41%

Merck & Co Inc Info

āļĄāļđāļĨāļ„āđˆāļēāļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒāļ•āļēāļĄāļĢāļēāļ„āļēāļ•āļĨāļēāļ”
āļŋ9.67T

1.41%

āļ›āļĢāļīāļĄāļēāļ“āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļĢāļēāļĒāļ§āļąāļ™
āļŋ33.3B
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ
āļ›āļĢāļ°āđ€āļ āļ—āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒ
āļŦāļļāđ‰āļ™
āļžāļ™āļąāļāļ‡āļēāļ™
75000
āļāđˆāļ­āļ•āļąāđ‰āļ‡
Jan 1, 1891
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĩāđˆāđƒāļŠāđ‰āļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ
New York Stock Exchange
āļ­āļļāļ•āļŠāļēāļŦāļāļĢāļĢāļĄ
Pharmaceutical Preparations
āļŦāļĄāļēāļĒāđ€āļĨāļ‚āļ›āļĢāļ°āļˆāļģāļ•āļąāļ§
0000310158

āļ‚āđ‰āļ­āļĄāļđāļĨāļŦāļļāđ‰āļ™āļ—āļĩāđˆāđāļ›āļĨāļ‡āđ€āļ›āđ‡āļ™āđ‚āļ—āđ€āļ„āļ™

āļĢāļēāļ„āļēāđ€āļ‰āļĨāļĩāđˆāļĒāļ‚āļ­āļ‡āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ—āļĩāđˆāđāļ›āļĨāļ‡āđ€āļ›āđ‡āļ™āđ‚āļ—āđ€āļ„āļ™
āļŋ4K
āļ„āļ§āļēāļĄāļ•āđˆāļēāļ‡āļ‚āļ­āļ‡āļĢāļēāļ„āļē
+āļŋ89.32(+2.28%)
āļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”āļ‚āļ­āļ‡āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāđƒāļ™āļĢāļđāļ›āđāļšāļšāđ‚āļ—āđ€āļ„āļ™
āļŋ1.26B

2.85%

āļ›āļĢāļīāļĄāļēāļ“āļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāđƒāļ™āļĢāļđāļ›āđāļšāļšāđ‚āļ—āđ€āļ„āļ™ (24 āļŠ.āļĄ.
āļŋ33.5M

4.08%

āļœāļđāđ‰āļ­āļ­āļ
āļŠāļąāļāļāļē
āļŠāļģāļĢāļ§āļˆ
āļĢāļ°āļšāļšāđāļ›āļĨāļ‡ MRK āđ€āļ›āđ‡āļ™ USD
MRK
THB
āļāļēāļĢāļ›āļĢāļ°āđ€āļĄāļīāļ™āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāļ•āđˆāļ­āļĢāļēāļ„āļē
āļ•āđˆāļģ
āļŋ3.9K
āļŠāļđāļ‡
āļŋ4K

āļāļģāļĨāļąāļ‡āđ‚āļŦāļĨāļ”āļ‚āđ‰āļ­āļĄāļđāļĨ

āđ‚āļ›āļĢāļ”āļĢāļ­āļŠāļąāļāļ„āļĢāļđāđˆ āđ€āļĢāļēāļāļģāļĨāļąāļ‡āđ‚āļŦāļĨāļ”āļ‚āđ‰āļ­āļĄāļđāļĨāđāļœāļ™āļ āļđāļĄāļī

Merck & Co Inc āļŠāļļāļĄāļŠāļ™

skeleton-white
 
 
 
 
 
 

About Merck & Co Inc

What is Merck & Co Inc?

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

āļ‚āđ‰āļ­āļĄāļđāļĨāļĢāļēāļ„āļēāļŠāļ” Merck & Co Inc

The current price of Merck & Co Inc in the market is āļŋ3,917.39, with a 24-hour trading volume of āļŋ33.3B. The asset's market cap is āļŋ9.67T, after moving -1.42% in the last day.

Tokenized Merck & Co Inc is trading at āļŋ4,006.71, with a tokenized market cap of āļŋ1.26B and a 24-hour trading volume of āļŋ33.5M. The tokenized asset has moved -2.85% in the past 24 hours.